PharmaMar
This article contains content that is written like an advertisement. (July 2020) |
Sociedad Anonima | |
BMAD: PHM | |
ISIN | ES0169501022 |
Industry | Pharmaceuticals |
Founded | 1986 |
Headquarters | Avda. de los Reyes, 1 Pol. In. La Mina, 28770, Colmenar Viejo, Community of Madrid, Spain |
Area served | Worldwide |
Key people | José María Fernández Sousa-Faro |
Products | Prescription drugs for central nervous system disorders and oncology |
Revenue | €162.6 million (2018)[1] |
(€14.072 million) (2018)[1] | |
(€4.632 million) (2018)[1] | |
Total assets | €157.676 million (2018)[1] |
Number of employees | 600 (2018)[1] |
Subsidiaries | Genomica Sylentis Zelnova (2015–2019) Xylacel (2015–2018) |
Website | pharmamar |
PharmaMar is a Spanish
PharmaMar's key ventures include the
History
Zeltia (1939–2015)
In 1963, Zeltia began to be listed in the stock exchange of Madrid. In 1964, it created three subsidiaries dedicated to the agricultural industry (Zeltia Agraria), the pharmaceutical industry (ICI Farma) and the chemical-veterinary industry (Zelnova) respectively. After an agreement with the German Desowag Bayer Holszschutz, in 1975 the Xylacel brand was created, which markets products for the treatment of wood and metal.
In 1984, Antibioticos SA and ICI Farma were released from the Zeltia group and in 1986 José María Fernández Sousa-Faro founded the PharmaMar subsidiary with the objective of developing
PharmaMar (2015–)
In 2015, with the aim of focusing in the group's main business, PharmaMar absorbed the entire Zeltia group by means of a reverse merger. In 2018, the Xylacel brand was sold to the
External links
References
- ^ a b c d e PharmaMar 2018 Annual Report
- ^ "BRIEF-Zeltia to propose reverse merger with PharmaMar". Reuters. 26 February 2015. Retrieved 7 March 2020.
- ^ "Bolsa de Madrid – Precios de la sesión por sectores IGBM: Petróleo y Energía". bolsamadrid.es. Retrieved 7 March 2020.
- ^ "Oncology Pipeline | Pharmamar S.A". Pharmamar. 13 May 2018. Retrieved 7 March 2020.
- ^ "Genómica (Pharmamar) logra certificado CE para kit de detección coronavirus". efe.com (in Spanish). Retrieved 7 March 2020.
- ^ "PharmaMar logra luz verde para comercializar los tests de diagnóstico del coronavirus". EXPANSION (in Spanish). 6 March 2020. Retrieved 7 March 2020.
- ^ "Una empresa española lanzará los primeros kits de diagnóstico rápido de coronavirus". abc (in Spanish). 1 March 2020. Retrieved 7 March 2020.
- ^ "Our expertise". SYLENTIS S.A. | Ophthalmic RNAi Pharmaceuticals. Retrieved 7 March 2020.
- ^ "Grupo Zeltia". Vigoempresa.com. Retrieved 8 August 2023.
- ^ "Oncology Pipeline | Pharmamar S.A". Pharmamar. 13 May 2018. Retrieved 7 March 2020.
- ^ "Search of: trabectedin - List Results - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 7 March 2020.
- ^ KG, Vincentz Network GmbH & Co. "Akzo Nobel acquires Xylazel in Spain". European Coatings. Retrieved 7 March 2020.
- ^ "El fabricante gallego de vacunas Zendal compra Zelnova, filial de PharmaMar". La Voz de Galicia (in Spanish). 24 May 2019. Retrieved 7 March 2020.
- ^ "Genómica (Pharmamar) logra certificado CE para kit de detección coronavirus". efe.com (in Spanish). Retrieved 7 March 2020.